Q3 2021 Ingredion Inc Earnings Call

[music].

Good morning, ladies and gentlemen, and welcome to ingredient third quarter 2021 earnings conference call. At this time all participants are in a listen only mode. After the speaker's presentation. There will be a question and answer session to ask a question. During this session you will need to questions pardon. The one key on you touched on the telephone.

Please be advised todays conference is being recorded.

If you recall our assistance. Please press Star then zero.

I would now like to turn the call things over to your speaker host today.

So Jason plan, Vice President of corporate Finance and interim Vice President of Investor Relations.

Thank you.

Good morning, and welcome to ingredients third quarter 2021 earnings call.

Jason Pan Vice President of corporate Finance and interim Vice President of Investor Relations on today's call are Jim Sally, our president and CEO and Jim Gray, our executive Vice President and Chief Financial Officer.

We issued our results today in a press release that can be found on our website ingredient dot com in the investors section. The slides accompanying this presentation can also be found on the website and were posted today for your convenience.

As a reminder, our comments within this presentation may contain forward looking statements. These statements are subject to various risks and uncertainties and include expectations and assumptions regarding the company's future operations and financial performance, including the impact of the COVID-19 pandemic.

Actual results could differ materially from those estimated in the forward looking statements and ingredient assumes no obligation to update them in the future as or if circumstances change and.

Additional information concerning factors that could cause actual results to differ materially from those discussed during today's conference call.

Or in this morning's press release can be found in the company's most recently filed annual report on Form 10-K, and subsequent reports on forms 10-Q and 8-K.

During this call. We also refer to certain non-GAAP financial measures, including adjusted earnings per share adjusted operating income and adjusted effective tax rate, which are reconciled to U S. GAAP measures and note to non-GAAP information included in our press release and in today's presentation appendix.

Now I'm pleased to turn the call over to Jim Sally.

Thank you, Jason and good morning, everyone.

We delivered outstanding third quarter topline performance of 17% net sales growth.

This reflected well managed sales execution to meet strong customer demand.

In every region, we achieved double digit sales growth by managing price mix and partnering with customers to meet changing demand requirements as a result of global supply chain constraints.

In a challenging environment.

And against previously anticipated high double digit corn cost inflation.

We kept pace with higher input costs to deliver adjusted operating income down 9%.

As you recall in the first half of this year.

We delivered significant year over year EPS growth.

Absorbing higher gross corn costs.

While benefiting from higher co product values.

Taken together as we balanced first half favorability with higher net corn costs in the second half.

We are still on track to deliver significant operating income growth for.

For the full year.

Now I'd like to highlight a few of our sales achievements.

As mentioned, we grew net sales by double digits across all regions driven by strong specialty demand and actively managing the terms of our customer contracts, including the pass through of higher margin corn and freight costs.

EMEA led our growth this quarter with strong specialty demand in Europe.

And the positive impact of the <unk> acquisition.

Asia Pacific also performed exceptionally well driven by contributions from pure circle and strong overall specialty demand.

South America, and North America benefited from strong customer demand and the pass through of higher corn and freight costs.

Now I'd like to comment on the current supply chain environment that we're all reading about.

As everyone knows.

Supply chains globally are currently constrained by ocean container availability.

Rail congestion.

Labor shortages and continuing impacts of the pandemic.

In addition, as economies continue to open strong international consumer demand has made the current supply situation very challenging.

To put the impact of the supply chain challenges into perspective on our business.

As a reminder, the majority of our volume is sourced locally and delivered locally within region How's.

However for a portion of our specialty food starch business, we have an inter regional supply chain.

For example about 5%.

Of our U S sales are imported from Asia Pacific of which most are specialty food starches.

Therefore in the first half of this year, we resource our global supply chain center of excellence to actively manage inner regional sourcing and work closely with customers to identify opportunities to best service their needs.

In some special circumstances, we've had to exercise agility to meet customer demand for tapioca and rice based starches by air Freighting product to meet new product launches or assist with product re formulations.

We anticipate the supply chain to remain constrained through the end of this year.

Okay.

Now moving onto our strategic pillars, we.

We continued to make solid progress against each of our strategic pillars throughout the quarter executing on key initiatives to advance our strategy.

Our specialty ingredients platforms continue to be a catalyst for significant growth achieving high teens net sales growth for the quarter.

And exceeding the company's net sales growth.

Among the highlights our sugar reduction and specialty sweeteners growth platform.

<unk> the most sales dollar growth in the quarter.

Additionally, consumers' heightened focus on nutrition and wellness underpinned the robust demand in Q3.

For our clean and simple texture and plant based protein solutions.

Moving to commercial excellence, our sales teams around the World responded early in the quarter to the challenge of increasing input costs through pricing actions and by managing commercial terms, which helped us mitigate inflationary impacts to our business.

While margins were pressured.

On a dollar basis, we recovered nearly all of the cost inflation that we faced in the quarter.

Cost smart continues to deliver benefits and have a transformational effect across our company as we continue to find ways to reinvent, how we work and deliver increased efficiencies and savings.

This quarter, we extended our shared service capabilities implementing a major change management program within our global human resources function that will provide better and more cost efficient HR services.

Overall, we remain on track to deliver against our three year cost smart savings program of $170 million, which we've increased twice.

Since it was introduced in 2018.

All of this progress.

Is underpinned by our purpose and values driven people centric culture.

As I'll speak about in more detail. Shortly this quarter, we are particularly proud to have released our first diversity equity and inclusion report, where we shared our progress to date and our commitments for the future.

Before discussing this let me first provide some important updates on the progress we're making in our specialties portfolio.

First turning to sugar reduction.

Or circle continues to be a catalyst for growth in our sugar reduction and specialty sweeteners platform.

During the quarter pure circle net sales were up more than 200% year over year and operating losses decreased by 60% with both metrics well ahead of our integration plan.

Additionally, I'm happy to share that the acquisition is now cash accretive.

With a number of recent customer wins and a robust new project pipeline, our sugar reduction and specialty sweeteners team is energized about future growth prospects.

Now moving on to plant based proteins.

We continue to see strong demand for plant based protein innovation from both existing and.

And new customers.

And albeit off a small base, our net sales doubled for the second consecutive quarter.

And our project pipeline remains robust.

We are intensively focused on increasing supply.

And ramping up our facilities in South Sioux City, Nebraska, and Vanscoy, Canada.

Our dry milk production in Vanscoy has reached new monthly production records and we've just commissioned our specialties concentrates production line in September which will increase our available supply of these differentiated products by year end.

In South Sioux City, our startup continues to make steady progress with production advancing and increases in batch size and consistency.

We estimate we are two thirds through commissioning and process stabilization and are targeting a steady state process that is able to meet our ramp up in customer demand early next year.

We are laser focused on beginning to load this facility and absorbing the costs associated with our new plant startup.

Our team is also actively managing yellow pea costs and availability as the drought in Canada has negatively impacted crop size and prices.

We are confident we have secured our yellow pea requirements for next year and are assessing the impact of increased raw material costs on next year's financial projections.

Before I hand, it over to Jim I want to spend a moment discussing our diversity equity and inclusion agenda.

We view, our purpose and values driven people centric culture as an important growth enabler.

At the heart of this is a deep commitment to diversity equity and inclusion.

Our inaugural report entitled Everyone belongs in recognition of one of our five values not only celebrates the accomplishments we've made on our <unk> journey, thus far.

But search new goals.

Like achieving 100% on Hrc's corporate equality index.

Reaching industry benchmarks for inclusion and belonging.

Improving representation of women in management positions to 50% by 2030.

And improving representation of black indigenous and people of color at the management level.

With these goals, we are intensifying our commitment to creating an environment, where diversity is celebrated and inclusion is embraced.

We know how important this is for us to attract the most talented employees and foster an inclusive and innovative culture that delivers sustainable growth for shareholders.

We've included a link in our earnings presentation, where you can download our new <unk> report.

And it is also available on our website.

Now, let me hand, it off to Jim Gray, who will provide a financial review of the quarter.

Thank you, Jim and good morning to everyone.

Starting first with our Q3 regional performance.

North America net sales were up significantly when compared to the prior year.

With America operating income was $120 million down 9% versus the prior year.

The decrease was driven by higher corn and input costs as well as cost absorption related to the ramp up of operations in our plant based protein facilities.

South America net sales were up 16% versus prior year.

The increase was driven by favorable price mix, including active contract management to reflect higher corn costs.

Partially offset by a volume decline due to the contribution of our Argentina operations to the <unk> joint venture in August.

South America operating income was $35 million up 21% versus prior year as favorable price mix more than offset higher corn costs.

Excluding foreign exchange impacts adjusted operating income was up 20% in the quarter.

Moving to Asia Pacific net sales were up 18% in the quarter.

The increase was driven by favorable price mix and higher volumes, primarily from pure circle.

Asia Pacific operating income was $21 million up 17% versus prior year as higher volumes from pure circle and better price mix were partially offset by higher corn freight and input costs in the region.

In EMEA net sales increased 22% for the quarter.

The increase was due to higher volumes, including our <unk> acquisition as well as favorable price mix.

Absent foreign exchange sales were up 20%.

EMEA operating income was $23 million down 8% for the quarter.

The decrease was driven by higher corn and energy costs in Pakistan.

More than offset higher volumes.

Moving to our income statement net sales of $1 $763 million were up 17% for the quarter versus prior year.

Gross profit dollars were relatively flat year over year, while gross margin was 18, 3% down 340 basis points due to increased revenue, reflecting the pass through of higher corn costs.

Reported operating income was $172 million and adjusted operating income was $163 million.

Reported operating income was higher than adjusted operating income primarily due to a favorable final adjustment to the net asset impairment related to the contribution of Argentina assets to the <unk> joint venture.

Partially offset by restructuring costs related to customer.

Our third quarter reported earnings per share was $1 75.

And adjusted earnings per share was $1 67.

Turning to our Q3 net sales bridge strong price mix of $212 million was largely attributable to the pass through of higher corn costs corn costs in North America, and active contract management and South America.

The sales volume increase of $39 million was driven by higher volumes in EMEA and Asia Pacific, including the sales volume impact of pure circle and K Tec.

Partially offset by the contribution of our Argentina operations to the <unk> joint venture.

Turning to net sales variance by region in North America, net sales were up 17% versus prior year, driven by favorable price mix as well as higher specialty ingredient mix.

South American net sales were up 16% driven by strong price mix, primarily due to active contract management to address higher corn costs.

Which was partially offset by a decline in volume from the contribution of our Argentina operations to the <unk> joint venture.

In Asia Pacific net sales were up 18% driven by favorable price mix and higher volumes, primarily from pure circle.

EMEA net sales were up 22% driven by higher volumes as demand in Europe for specialty ingredients was robust.

Sales volume also includes K Tec, which contributed eight points of net sales growth in the quarter.

For the quarter reported operating income increased $19 million, while adjusted operating income decreased $16 million.

The increase in reported operating income versus adjusted operating income is primarily due to the finalization and completion of the <unk> joint venture net asset impairment.

Partially offset by restructuring costs related to cost Mark.

Corporate costs for the company were up for the quarter versus last year, driven by investments in global capabilities at centers of excellence.

Turning to our earnings bridge on the left side of the page you can see the reconciliation from reported to adjusted earnings per share.

On the right side operationally, we saw a decrease of <unk> 18 per share for the quarter.

The decrease was primarily driven by operating margin decline of 26.

Partially offset by higher volumes of <unk> and favorable foreign exchange of <unk> <unk> per share.

Moving to our non operational items, we saw an increase of <unk> <unk> per share for the quarter.

Primarily driven by the impact of lower adjusted effective tax rate of <unk> 12 per share, partially offset by higher financing costs of <unk> <unk> per share.

For our year to date income statement. The company delivered net sales of $5 billion $139 million up 17% versus prior year.

Gross profit margin was 23% down 60 basis points.

Year to date reported operating income was $224 million.

And adjusted operating income was $572 million.

Reported operating income was lower than adjusted operating income due to the completion and finalization of the <unk> joint venture net asset impairments and restructuring costs related to cost Mark.

Partially offset by income related to the favorable decision from the Brazilians Supreme Court related to indirect taxes collected from 2015 to 2018.

Our year to date reported earnings per share was <unk> 74.

And adjusted earnings per share was $5 58.

Turning to our year to date net sales bridge, we see that all drivers of revenue contributed to growth.

Favorable price mix of $433 million was largely attributable to the pass through of higher corn costs in North America and South America.

Sales volume increase of $261 million was driven by higher volumes in Asia Pacific North America, and EMEA, including the additions of pure circle and K Tec.

These increases were partially offset by a decrease in South America sales, resulting from the completion of the <unk> joint venture.

Our year to date operating income bridge reported operating income decreased 190.

$195 million.

While adjusted operating income increased $99 million.

Versus prior year.

The decrease in year to date reported operating income versus adjusted operating income is primarily due to the net asset impairment charge related to the <unk> joint venture in Argentina.

Operating income was up in all four regions.

Year to date corporate costs for the company were up versus last year, driven by investments in global capabilities and centers of excellence.

Turning to our year to date earnings bridge on the left side of the page we show the reconciliation from reported to adjusted.

On the right side operationally, we saw an increase of $1 <unk> per share year to date.

The increase was driven by margin improvement of 47.

Higher volumes of 44.

Foreign exchange of <unk>.

And other income of <unk> <unk> per share.

Moving to our non operational items, we saw an increase of one penny per share year to date.

Moving to cash flow.

Year to date cash provided by operations was $259 million cash provided by operations decreased versus prior year, driven by the impact of higher net sales, including higher corn costs on accounts receivable and inventory values.

Capital expenditures were $186 million down $64 million from the prior year period due to the timing of spend.

During the quarter, we repurchased $44 million of outstanding shares.

<unk>, our total year to date share repurchase to $68 million.

With more clarity regarding how demand pricing and input cost inflation are playing out for the second half of 2021, we are increasing our full year 2021, adjusted EPS range to $6 65 to $7 per share.

Up from the previously provided full year outlook of $6 45 to $6 85.

We expect net sales to be up low double digits, driven by the pass through of higher corn costs strong price mix and volume recovery.

We expect full year adjusted operating income to be up high single digits versus last year.

We expect corporate cost to be up low single digits.

2021 financing costs are expected to be in the range of 78 million to $83 million.

Our adjusted effective annual tax rate is expected to be between 25, 5% and 27%.

Cash flow from operations is expected to be in the range of $450 million to $550 million, which includes an increase in expected working capital due to the impact of higher net sales as well as the impact of higher corn costs on accounts receivables and inventories.

Capital investment commitments are expected to be between $320 million and $350 million.

Of which more than $100 million has been invested to drive specialty growth.

We expect total diluted weighted average shares outstanding to be in the range of 67 $5 million to $68 million for the year.

In terms of our regional outlook North American net sales are expected to be up 10% to 15%.

Operating income is expected to be up low single digits to mid single digits, driven by higher volumes and lower operating expenses.

For South America, we assume the deconsolidation and contribution of our Argentina operations for five months of the year.

We expect net sales to be up 10% to 15% and operating income to be up 20% to 25%.

In Asia Pacific, We anticipate net sales to be up 20% to 25% versus the prior year, including pure circle.

We expect operating income to be up high single digits driven by higher volumes.

For EMEA, we expect net sales to be up 15% to 20%.

And operating income to be up high single digits, driven by higher volumes, which will be partially offset by higher input costs.

That concludes my comments and I'll hand, it back to Jim.

Thanks, Jim.

Overall, we are very pleased with both the financial performance in the quarter as well as the strategic progress we continue to make to strengthen our portfolio.

Right now we are focused on supporting our customers as we manage through complex supply chain bottlenecks, which are impacting the entire food supply chain.

And just as importantly, we are leveraging the expertise developed in our pricing centers of excellence that were built up over the last two years as we work to offset input cost inflation for the remainder of this year.

And next year.

We will continue to shape, our portfolio towards specialties and look for opportunities to invest in new capabilities and businesses that will strengthen the value propositions inherent in each of our on trend consumer focused growth platforms.

Lastly, we will continue to bring the potential of people nature and technology together to.

To make life better for all stakeholders.

Now, let's open the call for questions.

Ladies and gentlemen to ask a question at this time you will need to press. The Star then the one key on your Touchtone telephone.

A question press the pound key.

Please standby, while we compile the Q&A roster.

No first question coming from the line of Ben.

Yes, Ian Danon with Stephens, Inc. Your line is open.

Hey, Thanks, good morning, everybody.

Good morning, Ben Hey, Ben.

So I wanted to ask and focus on the specialty business. You noted global specialties contributed high teen sales growth continuing to drive strong growth across a lot of your products within that segment of your business.

You also talked about.

Improvement in the integration of pure circle could.

You provide some color on what sort of EBIT contribution, we're seeing from specialties relative relative to that sales growth that we're seeing and what you think.

The maturation of that contribution will look like over the next year or so as that portfolio continues to mature.

Sure Jim do you want to take the <unk> bin I'll, maybe I'll lead on that.

We've characterized our specialty ingredients portfolio, both from a gross margin and from an operating income margin perspective, as being greater than the remainder of our portfolio.

Traditionally, we see specialty margins in our products and the.

And the 30% plus range and it can be.

Some niche product can be significantly more than that on a gross margin basis and.

And generally what we're seeing is that as we have moved through this year in terms of various input costs.

They generally have less of an impact on our specialties because the raw material is a lower portion of our cost of sales and so as specialty continues to grow both on a volume basis on a market share gain basis.

And therefore on a revenue basis, we're seeing that that EBIT growth.

Somewhat in line with how we.

How we talk to the topline growth.

Yes, I think in our strategic plan for example, the majority of our gross profit increase over that planning period is coming from specialties and I think when you saw the most recent four year outlook that we had provided.

At the percentage of operating income coming from specialties is projected to increase.

Four percentage points I think over that that period from a standpoint of the weight of the overall portfolio. The other thing total the total mix. The other thing that I would add is.

Part of our strategy is to continue to invest in one of our five growth platforms, which is called food systems, which is leveraging the ingredients that are in those other four platforms starch based texture risers, the clean and simple ingredients sugar reduction in plant based proteins.

From a formulation capability standpoint to develop more complete.

Systems for our customers, which typically are higher gross margin and those.

We have projected that those will grow at a higher rate as well.

Okay. That's great. Thank you.

Secondly, I'd like to ask about just capital allocation you. It looks like based on the way things are going you'll probably continue to build cash on the balance sheet, even as you've accelerated to some extent your buyback activity you have got a steady steady dividend at a nice yield.

Further along in integrating pure circle, you noted that the pipeline is.

Interesting and attractive could you talk about.

When we think about rank ordering your use of cash over the next year or so.

One of the most versus lease likely outlets deploy that cash into.

Sure.

Then I'll tie your first question to your second question right, which is that.

As we grow the specialty portfolio, we are really looking for that that contribution in terms of operating income growth. So how can we get operating income growth mid single digit to high single digits, we do that by looking around the globe, but where we have capital investments organic capital investments that our team identifies.

And Thats really one of our first priorities in terms of capital investment after what I would call our stay in business capital and the reason why is that those opportunities are near end, they're adjacent they're strategic and.

Our whole team can really operate on our value chain and on the go to market opportunities. So for example, we're investing in a modified food starch expansion in China.

China is a tremendously underserved market for our modified starches and we can bring great differentiated product that sourced locally and made locally and sold into a massive market.

So that's the type of opportunities, where we first prioritize I think secondarily then we're really looking at.

We're very conscious about the dividend and dividend growth. We've raised the dividend seven years in a row and then third we still have excess cash to deploy strategically and it really its a choice between what M&A is there available to us that we think we can prudently go after and do so with a disciplined approach.

<unk> towards ROIC I think we've proven that we can we can get synergies out of the acquisitions that we've executed in the past still some of that evidence is for us to show we highlighted here on the call pure circle and the progress we're making on pure circle going into next year, So M&A tuck.

In M&A M&A in general is very much a focus for us and if not then we will go after some share repurchase and be very disciplined about total shareholder return.

That's great. Thanks, Jim Jim Good luck with the rest of the year.

Thank you Ben Thanks, Ben.

And our next question coming from the line of Robert Moskow with Credit Suisse. Your line is open.

Hi, a couple questions.

One is.

In Asia Pac it looks like you lowered your sales guidance for the year is that related to pure circle or is that related to just the challenge of of global trade.

And the tight supply chain environment, and then also can you elaborate a little more on the yellow pea crop and what that means for your operations.

What was your what youre going in assumption for profitability.

That new Pea protein business for 2022.

And what do you what do you think the potential outcomes are.

If the crop.

Turns out to be much more expensive.

Yes, I'll, let Jim take Asia Pac and I'll take the yellow question, yes.

Hey, Rob.

With regard to Asia Pac really as we looked at what we thought the recovery was.

From last year in terms of volume really if you look at Q3 South.

Southern Asia, right, whether it's Thailand in ASEAN any type of regions.

Or even.

Even China with kind of Intermit and Lockdowns.

Just been kind of some some ups and downs in terms of the volume growth as we've had.

Starts and stops in various food supply chains, as well as kind of ins and outs on foodservice. So so I think that Thats now where C that we see COVID-19 rates coming down we see it.

Consumer mobility App.

Thinking a bit more positively on Asia Pac for Q4, but really when we just take Q3 and what maybe that slight pause had into effect I think thats impacting our full year outlook and it really has nothing to do with pure circle peer circle growth is still.

Strong double digits.

And as far as the as far as the plant based protein investment in yellow.

We continue to remain very bullish on the growth prospects from both South Sioux City and the Vanscoy investments.

We absolutely believe that plant based proteins are going to represent a sizable portion of our specialty portfolio over the next three or five years.

We're very encouraged by the progress our manufacturing and engineering teams have made.

To commission two entirely new production facilities in a completely new ingredient category.

Two ingredients.

<unk>.

Vanscoy facility as we indicated continues to.

Produce at record rates in comparison to previous months.

Right now the focus is on south Sioux City, completing that process stabilization and ramping up that supply to meet customer demand.

Our plant based.

Protein sales in 2021 will be two to three times, what they were last year that said they will be behind our first year forecast and that's why we're laser focused on loading the facility and absorbing the cost associated with the new <unk>.

Plant startup so while this will result in a larger operating loss than we had projected.

This particular year, we're confident in the.

Long term prospects for the category and for the return on those investments.

And generally Rob I mean to add.

We see all of you.

Cost or the cost of the raw materials going up.

First indications are is that as such a value added product that that raw material pricing can be put through on the on the higher end protein isolate.

Okay. So when you say that the loss is larger than expected is that because the crop is weak or is it because of other types of delay.

No no. So again, we are just commissioning these facilities this calendar year so.

The yellow pea cost is not related to that at all.

No it's just related to the.

Merging of the commercial ramp up of the facilities tied to sales in the first year literally of commissioning both.

Both facilities.

Okay is it easy to catch up in year two than Jim like we've got a very large we've got a very strong we've got a very strong customer pipeline.

Having very strategic discussions with some.

One of the largest users and projected users for example, pea protein isolate and pulse based concentrates.

Across food and other applications and so we're feeling very good about the prospects going into 2022, yes, Rob Rob maybe just to help on.

<unk> City Theres, just more fixed costs with that facility just given the complexity of the process and so the more volume you get through you absorb the fixed costs in it and then you get right back on plan.

Okay last question in the quarter gross profit margin was below consensus.

It was it in line with what you thought internally or was a little light.

No I think it was in line with what we were expecting.

Recognizing look at in our business quite a bit of it is in terms of.

As we mentioned in North America portion is variable price. So it's a fee type contract revenue is going to go up as the cost of cost of corn goes up and we're really securing kind of our dollar profit per ton.

For the value add service that we provide.

So I think in terms of gross profit dollars.

Looking at the various corn cost inflation, which was probably three quarters of our change in our cost of sales for the quarter that was very in line with expectations.

Got it okay. Thanks.

And our next question coming from the line of Adam Samuelson with Goldman Sachs. Your line is open.

Yes. Thank you good morning, everyone.

Hi, Adam Hi, Adam Hi.

Hi.

So first question maybe.

Maybe just to clarify just as we think about the layout for the fourth quarter I think the full year guidance implies that.

<unk> operating profit in <unk> was down.

80% plus year over year.

Maybe just help us.

With where the incremental year on year pressures are coming through in <unk> relative to where you were in the third quarter and I know corn costs are more burdensome on the.

Second half of the year broadly, but it does seem to imply a bigger step down sequentially and I'm just trying to make sure we're clear on the drivers.

Sure. Thanks, Adam so in the first.

First I just wanted to bring us back to the first nine months of the year gross corn costs.

In line with our business plan and we benefited from higher co product values.

In addition.

Volumes, particularly specialties were stronger than anticipated due to the snapback of the global economies opening up inclusive of really very strong foodservice sales and in the third quarter, we kept pace with higher input costs to deliver operating income in line with our XP.

Patients against again previously anticipated high double digit corn cost inflation and we also delivered very strong price mix in quarter four.

We're anticipating further inflationary cost increase increases and some supply chain constraints limiting volume upside.

And we're obviously in.

Imposing price surcharges in year, which is what we've been doing.

And they will just lag some of the increase in input costs, but.

We're <unk>.

Taking all that into account as we go into our contracting and pricing for next year with momentum on the pricing side.

Yes, and Adam just to remind right.

Q3 is usually a bigger quarter than Q4.

And that as we had previously discussed and as Jim just mentioned just still managing through higher corn costs year over year.

That's the primary impact that we're seeing in terms of Q4.

Okay Alright.

That's helpful and then.

Follow up question and you kind of alluded to it a little bit of that answer just now Jim but.

Also throughout the.

Our call today made several allusions to actively managing.

Customer contracts and pricing and being considerably more proactive on that then maybe angry and had been historically and I'd love to hear you reflect a little bit about what you're actually doing.

On the pricing side to really make sure youre getting that inflation recovery is that we.

Both in the more on the base commodity business and specialty is both.

Commodity is that.

At our <unk>.

Supply environment.

With volumes, improving or just help me think about how maybe ingredient kind of pricing discipline is maybe different today than it might've been a couple of years ago.

Yes, we've been emphasizing our what we call pricing centers of excellence for the last year plus.

And the best evidence of that is in South America.

So South America has.

<unk> developed very strong pricing muscles that have.

Been demonstrated in relationship to the magnitude of price mix.

Vis vis <unk> <unk>.

Forex devaluation.

Over each successive quarter over the last two years.

So much so that I think it was last quarter and this quarter.

It's almost a complete neutralization without even the lag. That's one example, so we've.

We've shaped we've shared best practices across the globe and staffed.

And were fortunate we did so.

Two inflation rearing its head Thats why were feeling very good in this particular year as it relates to extra.

Extraordinary times call for extraordinary measures when you're living through inflation in year, even though we're contracted we're looking at each and every contract where possible.

Where we can in year.

Exercise the terms that are in those contracts to put through rate increases.

Of an order of magnitude that offsets those cost increases surcharges were necessary.

And any other inflationary increases so we're doing that in each region based on those pricing centers of excellence and just if I could comment a little bit just on pricing as it relates to the go forward.

The increased economic activity and increased industry capacity utilization, we believe will be favorable to pricing next year.

Corn prices are as we all know trending in the mid $5 range for next year, which would imply substantial increases in corn costs.

And the industry is contending with the increases in chemicals packaging fuel freight and all of that is going to need to be offset by pricing.

And.

Consistent with our operating model, we expect to pass through higher corn freight input cost to our customers and that's really been the primary focus.

To our customers since early summer and equally the pace of contracting is likely to be impacted by customers' concern for supply.

As well as the uncertainty around continued inflationary pressures and I can say for those customers.

We have agreed to 2022 commitments at this time, we're seeing substantial price increases year over year.

And we will provide a readout on 2022 contracting during our year end earnings call in February.

Alright, great that color is really helpful. I'll pass it on thanks.

Okay.

Our next question coming from the line of Ken Zaslow with BMO capital markets. Your line is open.

Hey, good morning, everyone.

Hi, Ken.

Just one bigger picture question your cash flow from.

Your cash flow guidance came down a little bit.

But you're obviously taking up expectations in your Capex is going down.

What is that in reference to just kind of given that little color that'd be helpful.

Sure, Hey, Hey, Ken just as you have higher corn and raw materials, just working from the raw material to the web to the finished goods and then we're selling those to customers. So youre volume may be.

Low single mid single digits, the price on that ton is.

Is benefiting from the pass through of that higher corn costs and so therefore, the invoice that goes to the customer as more and then as you just work through the various term terms with the customers in terms of their payables.

As sales grow we have to put a little bit more money into accounts receivable and then as that higher raw material costs is passing through our inventory be it with our finished goods and we're holding it.

While the number of units may be similar or even slightly more constrained or down year over year due to demand the value per unit the value per ton is up and so thats just reflecting in our balance sheet.

I really think this is as as this globally higher corn costs as move through the balance sheet in 2021 will.

We will be back to kind of a more normalized investment in working capital in 2022 and beyond.

Okay and then.

In terms of Europe.

<unk>.

Energy costs, how transient is that and do you expect to be able to start passing it through that we would start to see a different trajectory in 2022.

Yes.

One <unk>.

Significant item as it relates to input costs that we are.

Putting through as far as price increases go in Europe, Europe accounts for 55, Europe accounts for 55% of our sales in EMEA.

And in accordance with our risk management strategy, we hedge for Europe, our natural gas needs and we're covered well into next year. So.

Sure.

Monitoring the situation.

And we are.

Intending.

To put through increases to offset the inflationary increases.

With energy as well as other raw materials and other input costs for contracting for next year in Europe.

Okay and my final question in regards to kind of beat around the Bush on this I'm just going to go right after it.

Have you finished contracting in the U S and do you expect your <unk>.

To offset the corn prices.

Going forward and then I'll leave it there.

It's just too early.

We're in the midst of contracting as we always are at this point in time, but what I would repeat is that would repeat is that the.

Yes.

The market.

Given how.

Right.

Supply.

<unk> is related to very strong demand. So that's what we're seeing very strong demand and we could sell everything that we make and our plants are running very hard.

And there is.

There is acknowledgment if not acceptance in relationship to.

The need for price increases to offset inflationary increases and we're seeing that receptivity.

And is.

It's just too early to say, how it's all going to net out but right now where we sit.

We're feeling.

Good about the market's understanding and the receptivity for.

Yes price increases to offset inflationary increases.

Ken just to add.

It's November we're about a third of the way through I think are kind of flat contracting.

On that we have seen substantial price increases year over year, so as to Jim's comment right. There's still two thirds of our customers out there who are looking at their contracts and I think honestly I think customers are working through budgeting for next year and they are working through how does that fit into what their overall price increases need to be.

Their goods.

So we expect it to pick up this should be the time of the year when it should be really kind of closing out prior to Thanksgiving and the holidays and that percentage that Jim cited is totally in line with historical so its not anything thats unusual.

Great I really appreciate it guys. Thanks, Thank you Ken.

As a reminder to ask a question. Please press star one and you had touched on telephone.

Okay.

I'm showing no further questions at this time I would now like to turn the conference call back over to Mr. Jim Farley bought any closing remarks.

Thank you for joining us. This morning, everyone. We look forward to a time when we see each of you again in person.

Please note that we are targeting our investor day for the first half of 2022, when we expect to be able to accommodate in person gatherings and until then we want to thank you for your continued interest in ingredients.

Ladies and gentlemen that does conclude our conference for today. Thank you for your participation you may now disconnect.

Yes.

Okay.

Hi.

[music].

Yes.

Yes.

Yes.

Thanks.

Okay.

Okay.

Okay.

Okay.

[music].

Yes.

Okay.

Yes.

Okay.

In 2014.

[music].

No.

Okay.

Yes.

Okay.

[music].

Yes.

Yes.

Yes.

Okay.

Okay.

Okay.

No.

Okay.

Okay.

Thanks.

Okay.

Okay.

Okay.

Yes.

Okay.

Yes.

Yes.

Okay.

Yes.

Yeah.

Okay.

Yes.

Yes.

Yes.

Okay.

Okay.

Okay.

Yes.

Yes.

Okay.

Okay.

Sure.

Sure.

Yes.

Okay.

Okay.

Okay.

Yeah.

Okay.

Okay.

Yes.

Yes.

Yes.

Thank you.

Okay.

Sure.

Okay.

Okay.

Yes.

Yes.

Yes.

Yes.

Okay.

Okay.

Okay.

Yes.

Yes.

Okay.

Great.

Yes.

Okay.

Fair enough.

Okay.

[music].

[music].

[music].

[music].

Q3 2021 Ingredion Inc Earnings Call

Demo

Ingredion

Earnings

Q3 2021 Ingredion Inc Earnings Call

INGR

Tuesday, November 2nd, 2021 at 1:00 PM

Transcript

No Transcript Available

No transcript data is available for this event yet. Transcripts typically become available shortly after an earnings call ends.

Want AI-powered analysis? Try AllMind AI →